News | November 01, 2024
AbbVie to acquire Aliada Therapeutics
Strengthening focus in Alzheimer's disease and neuroscience pipeline
Strengthening focus in Alzheimer's disease and neuroscience pipeline
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Revolutionary technology will further boost OneSource’s scientific services offerings
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Subscribe To Our Newsletter & Stay Updated
